Example 5
1-[4-(6-Fluoro-1H-indol-3-yl)phenyl]-3-methyl-urea
This compound was prepared from Intermediate 1 and 1-methyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea according to the procedure described in Example 4. Purification was performed using preparative HPLC to afford the title compound (10 mg, 25%). Data: LCMS (B) Rt: 9.719 min; m/z 284.2 (M+H)+.